The company utilizes innovative molecular technologies, such as TEM-PCR™, to identify bacteria regardless of recent antibiotic use, detect difficult-to-culture pathogens, and offer a high level of sensitivity and specificity. Their testing services cover various diseases including Pneumonia, ENT infection, influenza, Pharyngitis, respiratory infections, and sexually transmitted diseases, enabling efficient disease diagnosis for healthcare professionals. Eurofins Diatherix is a research firm specializing in TEM-PCR, diagnostics, infectious disease, molecular, and respiratory infection services.